Concepedia

HBsAg loss in patients treated with peginterferon alfa-2a and adefovir is associated with SLC16A9 gene variation and lower plasma carnitine levels

Louis Jansen, A. de Niet, F. Stelma, Erik P.A. van Iperen, Karel A. van Dort, Marjan J. Tempelmans Plat-Sinnige, R. Bart Takkenberg, Daniel J. Chin, A. H. Zwinderman, Uri Lopatin,

Journal of Hepatology · 2014 · 21 citations · 29 references

DOI

Concepts

References

29

Principal components analysis corrects for stratification in genome-wide association studies

Alkes L. Price, Nick J. Patterson, Robert M. Plenge et al. · Nature Genetics · 2006 · 10.7K citations

, , +12

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

Journal of Hepatology · 2012 · 2.9K citations · Full text

, , +17

Chronic hepatitis B: Update 2009 #

Anna S. Lok, Brian J. McMahon · Hepatology · 2009 · 2.8K citations · Full text

, , +17

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

George Lau, Teerha Piratvisuth, Kang Luo et al. · New England Journal of Medicine · 2005 · 1.5K citations · Full text

, , +14

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Harry L.A. Janssen, Monika van Zonneveld, Hakan Şentürk et al. · The Lancet · 2005 · 1.2K citations

, , +15